Coherus BioSciences, Inc.
NASDAQ:CHRS
1.05 (USD) • At close September 18, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -237.892 | -291.754 | -287.1 | 132.244 | 89.833 | -209.409 | -238.286 | -127.788 | -223.938 | -87.177 | -53.635 | -33.018 |
| Afschrijvingen & Amortisatie
| 3.791 | 3.699 | 3.454 | 2.888 | 3.259 | 3.235 | 3.398 | 2.996 | 1.869 | 0.674 | 0.404 | 0.221 |
| Uitgestelde Inkomstenbelasting
| 30.479 | 0 | 9.438 | -0.155 | -0.055 | 3.56 | 0.453 | -1.306 | 1.682 | 13.851 | 12.322 | -7.008 |
| Aandelen Gebaseerde Vergoedingen
| 43.11 | 50.737 | 51.364 | 38.16 | 33.591 | 34.797 | 36.065 | 27.421 | 16.721 | 11.062 | 2.045 | 0.443 |
| Verandering in Werkkapitaal
| -36.826 | -79.257 | 42.36 | -32.48 | -113.928 | 10.297 | -5.133 | -159.214 | 91.115 | 28.434 | 41.415 | 11.641 |
| Vorderingen
| -150.683 | 13.052 | 34.062 | -15.218 | -141.992 | 8.278 | 1.859 | -0.299 | 0.857 | -2.139 | -0.12 | -0.158 |
| Voorraden
| -46.734 | -47.348 | -6.253 | -36.188 | -48.184 | -5.484 | -0.148 | 8.256 | -1.269 | -16.157 | -0.384 | 0.122 |
| Crediteuren
| 23.76 | -4.548 | 0.874 | -9.82 | 9.893 | -0.534 | -4.454 | -7.636 | 19.932 | 5.266 | -0.386 | 3.378 |
| Overig Werkkapitaal
| 136.831 | -40.413 | 13.677 | 28.746 | 66.355 | 8.037 | -2.39 | -159.535 | 71.595 | 41.464 | 42.305 | 8.299 |
| Overige Niet-Contante Posten
| 22.454 | 75.451 | 143.052 | 5.988 | 15.655 | -1.746 | 3.217 | 5.346 | 4.561 | 9.229 | 12.872 | 9.47 |
| Kasstroom uit Operationele Activiteiten
| -174.884 | -241.124 | -37.432 | 154.145 | 28.355 | -159.266 | -200.286 | -252.545 | -107.99 | -23.927 | 15.423 | -18.251 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -0.286 | -2.039 | -1.289 | -7.056 | -12.897 | -0.789 | -4.573 | -6.515 | -6.164 | -2.849 | -0.373 | -1.783 |
| Netto Overnames
| 0.845 | 0 | 1.289 | 0.175 | 1.657 | -0.7 | 0 | 0 | 0 | 2.334 | 0 | 0 |
| Aankoop van Beleggingen
| -19.507 | -127.382 | -182.485 | -273.845 | -20.235 | -42.869 | -74.344 | 0 | -0.785 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 157.642 | 0 | 181.364 | 274 | 20.4 | 43.17 | 74.5 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 5.946 | -37.429 | -137.289 | -7.675 | -1.657 | 0.301 | 0.156 | -6.515 | -0.785 | -0.01 | 0 | -0.04 |
| Kasstroom uit Investeringsactiviteiten
| 144.64 | -166.85 | -138.41 | -14.401 | -12.732 | -1.188 | -4.417 | -6.515 | -6.949 | -0.525 | -0.373 | -1.823 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| 0 | -190.75 | -0.672 | -1.268 | -72.955 | 0 | 0 | -100 | 0 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 74.221 | 6.358 | 40.903 | 21.229 | 8.153 | 101.748 | 206.849 | 127.623 | 113.374 | 85.419 | 0.006 | 0 |
| Terugkoop van Gewone Aandelen
| -3.587 | -3.744 | -1.753 | -0.88 | -0.815 | 0 | -0.544 | -0.705 | -0.685 | -0.002 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| -4.621 | 246.206 | 15.154 | 225.214 | 227.127 | 3.673 | 0.482 | 126.179 | 122.689 | 50.539 | 9.95 | 26.938 |
| Kasstroom uit Financieringsactiviteiten
| 69.6 | 54.326 | 51.879 | 223.946 | 89.37 | 105.421 | 206.787 | 226.179 | 122.689 | 135.956 | 9.956 | 26.938 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0.44 | 0 | 0 | 0 | -0.276 | 0.468 | -0.12 | -0.398 | 0.084 | -0.666 | 0 | 0 |
| Netto Kasstroomverandering
| 39.344 | -353.648 | -123.963 | 363.69 | 104.717 | -54.565 | 1.964 | -33.279 | 7.834 | 110.838 | 25.006 | 6.864 |
| Kaspositie aan het Einde van de Periode
| 102.891 | 63.987 | 417.635 | 541.598 | 177.908 | 73.191 | 126.911 | 124.947 | 158.226 | 150.392 | 39.554 | 14.548 |